|
Volumn 39, Issue 1, 1996, Pages 65-72
|
Prerequisites for an effective treatment of chronic recurrent vaginal candidosis;Voraussetzungen fur eine effektive therapie chronisch rezidivierender vaginalcandidosen
a,d a b b c d d |
Author keywords
antifungal susceptibility; Chronic recurrent vaginal candidosis; fungal spectrum; therapy
|
Indexed keywords
CANDIDIN;
FLUCONAZOLE;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
ITRACONAZOLE;
NYSTATIN;
ANTIFUNGAL AGENT;
ADOLESCENT;
ADULT;
AGED;
ANTIBODY TITER;
ARTICLE;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA KRUSEI;
CHILD;
CHRONIC DISEASE;
DRUG EFFICACY;
DRUG SENSITIVITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RECURRENT INFECTION;
VACCINATION;
VAGINA CANDIDIASIS;
VAGINA DISCHARGE;
VAGINITIS;
VULVA PRURITUS;
YEAST;
CANDIDA;
CLINICAL TRIAL;
DRUG EFFECT;
GROWTH, DEVELOPMENT AND AGING;
ISOLATION AND PURIFICATION;
MICROBIOLOGICAL EXAMINATION;
MIDDLE AGED;
PATHOLOGY;
PATHOPHYSIOLOGY;
PRESCHOOL CHILD;
RECURRENT DISEASE;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
ISSATCHENKIA ORIENTALIS;
ADOLESCENT;
ADULT;
AGED;
ANTIFUNGAL AGENTS;
CANDIDA;
CANDIDA ALBICANS;
CANDIDIASIS, VULVOVAGINAL;
CHILD;
CHILD, PRESCHOOL;
CHRONIC DISEASE;
FEMALE;
FLUCONAZOLE;
HUMANS;
ITRACONAZOLE;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
NYSTATIN;
RECURRENCE;
|
EID: 0030039111
PISSN: 09437312
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (31)
|
References (16)
|